Diagnostic Challenges in Unusual Causes of Refractory GERD-Like Symptoms
DOI:
https://doi.org/10.12775/JEHS.2026.91.70866Keywords
refractory GERD, esophageal motility disorders, eosinophilic esophagitis, belching, rumination syndrome, gastroparesis, Zollinger-Ellison syndromeAbstract
Background: Refractory gastroesophageal reflux disease (GERD) describes persistent
reflux‑like symptoms despite optimized proton pump inhibitor therapy and is frequently driven
by alternative or overlapping pathologies rather than uncontrolled acid exposure.
Aim: To review unusual causes of refractory GERD‑like symptoms, with emphasis on
pathophysiology, diagnostic pitfalls, and practical evaluation strategies for achalasia,
eosinophilic esophagitis, belching and rumination disorders, gastroparesis, and Zollinger-Ellison
syndrome (ZES).
Material and methods: A review of selected literature was conducted using the PubMed database.
The search was performed using keywords including “refractory GERD,” “PPI refractory,”
“achalasia,” “gastroparesis,” “esophageal motility disorders,” and “case reports”.
Results: Achalasia, eosinophilic esophagitis, behavioural belching and rumination, gastroparesis,
and gastrinoma‑driven acid hypersecretion all produce GERD‑like complaints yet require
distinct diagnostic tools such as high‑resolution manometry, esophageal biopsies, impedance-
pH monitoring, gastric emptying studies, and fasting gastrin measurement. Failure to recognize
these entities risks inappropriate escalation of antireflux therapy, unnecessary surgery, and
progression to complications.
Conclusions: Systematic physiologic and endoscopic evaluation of PPI‑refractory symptoms is
essential to uncover uncommon causative conditions, align therapy with underlying mechanisms,
and prevent mislabeling patients with simple GERD when they harbour distinct motility,
inflammatory, behavioural, or neuroendocrine disorders.
References
[1] Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG
Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am
J Gastroenterol. 2022 Jan 1;117(1):27-56. doi: 10.14309/ajg.0000000000001538. PMID:
34807007; PMCID: PMC8754510.
[2] Yadlapati R, DeLay K. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Med Clin North Am. 2019 Jan;103(1):15-27. doi: 10.1016/j.mcna.2018.08.002. Epub 2018 Nov
1. PMID: 30466671; PMCID: PMC6260943.
[3] Wang G, Zhu C, Yin J. Etiology and treatment options for refractory gastroesophageal reflux
disease: A scope review. Clinics (Sao Paulo). 2025 Jan-Dec;80:100763. doi:
10.1016/j.clinsp.2025.100763. Epub 2025 Sep 20. PMID: 40976133; PMCID: PMC12489830.
[4] Davis TA, Gyawali CP. Refractory Gastroesophageal Reflux Disease: Diagnosis and
Management. J Neurogastroenterol Motil. 2024 Jan 30;30(1):17-28. doi: 10.5056/jnm23145.
PMID: 38173155; PMCID: PMC10774805.
[5] Zhang N, Wang Y, Fang SS, Han M, Zheng QW, Zhu YY, Zhang MY, Li JJ, Cui LX, Tian
JL, Deng YH, Zhu SL, Ni HM, Zhou L, Zuo GL, Huang TS, Liao Q, Li XQ, Shang YY, Wang
YJ, Tian Y, Ge LY, Han HQ, Hu WM, Jiang Y, Li YJ, Mao X, Yang LH, Yao JM, Zheng X,
Wang HW, Fang SQ. Clinical characteristics and risk factors of refractory gastroesophageal
reflux disease: A multicenter cross-sectional study. World J Gastroenterol. 2025 Dec
7;31(45):113060. doi: 10.3748/wjg.v31.i45.113060. PMID: 41378325; PMCID: PMC12686995.
[6] Bucan JI, Braut T, Krsek A, Sotosek V, Baticic L. Updates in Gastroesophageal Reflux
Disease Management: From Proton Pump Inhibitors to Dietary and Lifestyle Modifications.
Gastrointestinal Disorders. 2025; 7(2):33. https://doi.org/10.3390/gidisord7020033
[7] Valdovinos Díaz MA, Amieva-Balmori M, Carmona-Sánchez R, Coss-Adame E, Gómez-
Escudero O, González-Martínez M, Huerta-Iga F, Morel-Cerda E, Remes-Troche JM, Tamayo-
de la Cuesta JL, Torres-Villalobos G, Valdovinos-García LR, Vázquez-Elizondo G, Villar-
Chávez AS, Arenas-Martínez JA. Good clinical practice recommendations for the diagnosis and
treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana
de Gastroenterología. Rev Gastroenterol Mex (Engl Ed). 2024 Jan-Mar;89(1):121-143. doi:
10.1016/j.rgmxen.2023.12.002. Epub 2024 Apr 4. PMID: 38580493.
[8] Lin S, Li H, Fang X. Esophageal Motor Dysfunctions in Gastroesophageal Reflux Disease
and Therapeutic Perspectives. J Neurogastroenterol Motil. 2019 Oct 30;25(4):499-507. doi:
10.5056/jnm19081. PMID: 31587540; PMCID: PMC6786454.
[9] Vayal-Veettil A, Gyawali CP. Diagnosis and Management of Gastroesophageal Reflux
Disease: Current Insights. Clin Exp Gastroenterol. 2025 Jul 8;18:149-162. doi:
10.2147/CEG.S507237. PMID: 40656590; PMCID: PMC12255250.
[10] Lei WY, Yi CH, Liu TT, Hung JS, Wong MW, Chen CL. Esophageal motor abnormalities
in gastroesophageal reflux disorders. Tzu Chi Med J. 2024 Mar 26;36(2):120-126. doi:
10.4103/tcmj.tcmj_209_23. PMID: 38645779; PMCID: PMC11025585.
[11] Ganesh Shashi B, Hafsa SN. Current Advances in Diagnosis, Therapeutics, and Surgical
Interventions for the Management of Refractory Gastroesophageal Reflux Disease (GERD): An
Update. Cureus. 2024 Sep 9;16(9):e69001. doi: 10.7759/cureus.69001. PMID: 39385893;
PMCID: PMC11463874.
[12] Labenz J, Schoppmann SF. Improving treatment of people with gastro-esophageal reflux
disease refractory to proton pump inhibitors. Commun Med (Lond). 2024 Oct 14;4(1):200. doi:
10.1038/s43856-024-00632-6. PMID: 39397153; PMCID: PMC11471847.
[13] Kahrilas PJ, Keefer L, Pandolfino JE. Patients with refractory reflux symptoms: What do
they have and how should they be managed? Neurogastroenterol Motil. 2015 Sep;27(9):1195-
201. doi: 10.1111/nmo.12644. PMID: 26303047; PMCID: PMC4551076.
[14] Snyder DL, Katzka DA. Complex Gastroesophageal Reflux Disease. Gastro Hep Adv. 2022
Apr 5;1(3):420-430. doi: 10.1016/j.gastha.2022.02.014. PMID: 39131678; PMCID:
PMC11307939.
[15] Hosaka H, Kuribayashi S, Itoi Y, Sato K, Tanaka H, Takeuchi Y, Uraoka T. The Role of
Endoscopy in Gastroesophageal Reflux Disease. Digestion. 2025 Sep 24:1-9. doi:
10.1159/000548088. Epub ahead of print. PMID: 40991519.
[16] Chai C, Krishnan U. Dysmotility in Eosinophilic Esophagitis. Front Pediatr. 2022 Feb
28;10:853754. doi: 10.3389/fped.2022.853754. PMID: 35295702; PMCID: PMC8918583.
[17] Fernicola A, Parmeggiani D, Crocetto F, Calogero A, Cece A, Romano D, Benassai G,
Quarto G, Santangelo M. Esophageal Perforation in Zollinger-Ellison Syndrome: A Scoping
Review of Management and Outcomes. JGH Open. 2026 Jan 22;10(1):e70323. doi:
10.1002/jgh3.70323. PMID: 41585576; PMCID: PMC12827053.
[18] Bentley B, Chanaa F, Clayton S. Complete Esophageal Obstruction: A Rare Complication
of Zollinger-Ellison Syndrome. ACG Case Rep J. 2023 Nov 15;10(11):e01205. doi:
10.14309/crj.0000000000001205. PMID: 38025843; PMCID: PMC10651347.
[19] Sawada A, Fujiwara Y, Sifrim D. Belching in Gastroesophageal Reflux Disease: Literature
Review. J Clin Med. 2020 Oct 20;9(10):3360. doi: 10.3390/jcm9103360. PMID: 33092195;
PMCID: PMC7590068.
[20] Eypasch E, Ebner M, Leers J. The Unusual Patient in a Reflux Center: Belching,
Rumination, Somatization as Pitfalls of Patient Selection for Anti-Reflux Surgery. Visc Med.
2025 Mar 11:1-6. doi: 10.1159/000545089. Epub ahead of print. PMID: 40330637; PMCID:
PMC12052369.
[21] Kim BJ, Kuo B. Gastroparesis and Functional Dyspepsia: A Blurring Distinction of
Pathophysiology and Treatment. J Neurogastroenterol Motil. 2019 Jan 31;25(1):27-35. doi:
10.5056/jnm18162. PMID: 30509017; PMCID: PMC6326193.
[22] Tavakkoli A, Sayed BA, Talley NJ, Moshiree B. Acid and non-acid reflux in patients
refractory to proton pump inhibitor therapy: is gastroparesis a factor? World J Gastroenterol.
2013 Oct 7;19(37):6193-8. doi: 10.3748/wjg.v19.i37.6193. PMID: 24115816; PMCID:
PMC3787349.
[23] Subedi D, Parajuli BR, Bista N, Rauniyar S, Dhonju K, Bhusal S, Aryal E, Adhikari D,
Aryal S, Karna A. Achalasia cardia: A case report in young female. Clin Case Rep. 2024 Aug
5;12(8):e9239. doi: 10.1002/ccr3.9239. PMID: 39104735; PMCID: PMC11298990.
[24] Pesce M, Pagliaro M, Sarnelli G, Sweis R. Modern Achalasia: Diagnosis, Classification,
and Treatment. J Neurogastroenterol Motil. 2023 Oct 30;29(4):419-427. doi: 10.5056/jnm23125.
PMID: 37814432; PMCID: PMC10577462.
[25] Farah A, Assaf T, Hindy J, Abboud W, Mahamid M, Savarino EV, Mari A. The Dynamic
Evolution of Eosinophilic Esophagitis. Diagnostics (Basel). 2025 Jan 21;15(3):240. doi:
10.3390/diagnostics15030240. PMID: 39941170; PMCID: PMC11816659.
[26] Erdle SC, Carr S, Chan ES, Robertson K, Watson W. Eosinophilic esophagitis. Allergy
Asthma Clin Immunol. 2024 Dec 19;20(Suppl 3):72. doi: 10.1186/s13223-024-00929-0. PMID:
39702284; PMCID: PMC11660462.
[27] Arora AS, Yamazaki K. Eosinophilic esophagitis: asthma of the esophagus? Clin
Gastroenterol Hepatol. 2004 Jul;2(7):523-30. doi: 10.1016/s1542-3565(04)00236-8. PMID:
15224275.
[28] Wąsik J, Małecka-Wojciesko E. Eosinophilic Esophagitis-What Do We Know So Far? J
Clin Med. 2023 Mar 14;12(6):2259. doi: 10.3390/jcm12062259. PMID: 36983260; PMCID:
PMC10051236.
[29] Reed CC, Dellon ES. Eosinophilic Esophagitis. Med Clin North Am. 2019 Jan;103(1):29-
42. doi: 10.1016/j.mcna.2018.08.009. Epub 2018 Nov 1. PMID: 30466674; PMCID:
PMC6260964.
[30] Sawada A, Fujiwara Y. Belching Disorders and Rumination Syndrome: A Literature
Review. Digestion. 2024;105(1):18-25. doi: 10.1159/000534092. Epub 2023 Oct 16. PMID:
37844547.
[31] Woodley FW, Williams K, Di Lorenzo C, Michel HK. Significant Temporal Association of
Esophageal Air Events (Supragastric Belches, Air Swallows, and Gastric Belches) With
Hiccups: A Case Study in an Adolescent. JPGN Rep. 2022 Jun 21;3(3):e209. doi:
10.1097/PG9.0000000000000209. PMID: 37168628; PMCID: PMC10158523.
[32] Gyawali CP, Carlson DA, Chen JW, Patel A, Wong RJ, Yadlapati RH. ACG Clinical
Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol. 2020
Sep;115(9):1412-1428. doi: 10.14309/ajg.0000000000000734. PMID: 32769426; PMCID:
PMC9468980.
[33] Stojek M, Jasiński T. Gastroparesis in the intensive care unit. Anaesthesiol Intensive Ther.
2021;53(5):450-455. doi: 10.5114/ait.2021.110959. PMID: 34816707; PMCID: PMC10172955.
[34] Camilleri M, Sanders KM. Gastroparesis. Gastroenterology. 2022 Jan;162(1):68-87.e1. doi:
10.1053/j.gastro.2021.10.028. Epub 2021 Oct 27. PMID: 34717924; PMCID: PMC8678360.
[35] Grover M, Farrugia G, Stanghellini V. Gastroparesis: a turning point in understanding and
treatment. Gut. 2019 Dec;68(12):2238-2250. doi: 10.1136/gutjnl-2019-318712. Epub 2019 Sep
28. PMID: 31563877; PMCID: PMC6874806.
[36] R Sousa B, Rodrigues TB, Ribeiro J. When the Stomach Takes a Vacation: The Unseen
Battles of Gastroparesis. Cureus. 2024 Mar 16;16(3):e56263. doi: 10.7759/cureus.56263. PMID:
38623117; PMCID: PMC11017365.
[37] Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G. Multimodality evaluation of patients
with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor
therapy. Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub
2012 Aug 2. PMID: 22862422.
[38] Rossi RE, Elvevi A, Citterio D, Coppa J, Invernizzi P, Mazzaferro V, Massironi S.
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and
old therapies. World J Gastroenterol. 2021 Sep 21;27(35):5890-5907. doi:
10.3748/wjg.v27.i35.5890. PMID: 34629807; PMCID: PMC8475006.
[39] Shaik MR, Shaik NA, Kunarathnam V, Bilgrami Z, Wheeler E, Hu S. Esophageal
Perforation Unveiling the Diagnosis of Zollinger-Ellison Syndrome. J Community Hosp Intern
Med Perspect. 2023 Sep 2;13(5):77-81. doi: 10.55729/2000-9666.1228. PMID: 37868662;
PMCID: PMC10589047.
[40] Efared B, Tassiou EIM, Bako ABA, Boubacar I, Boureima HS, Nouhou H. Sporadic
Zollinger-Ellison syndrome in a patient with isolated mesenteric gastrinoma. Int J Surg Case
Rep. 2024 Mar;116:109474. doi: 10.1016/j.ijscr.2024.109474. Epub 2024 Mar 5. PMID:
38447521; PMCID: PMC10926117.
[41] Holzheimer RG, Mannick JA, editors. Surgical Treatment: Evidence-Based and Problem-
Oriented. Munich: Zuckschwerdt; 2001. PMID: 21028753.
[42] Jensen RT, Ramos-Alvarez I, Norton JA. Current Medical Controversies in Zollinger-
Ellison Syndrome. Biomedicines. 2025 Dec 11;13(12):3051. doi:
10.3390/biomedicines13123051. PMID: 41463062; PMCID: PMC12730841.
[43] Klimko A, Plotogea O, Constantinescu A, Constantinescu G. Delayed Management of
Zollinger-Ellison Syndrome in a Noncompliant Patient. Cureus. 2020 Jun 6;12(6):e8471. doi:
10.7759/cureus.8471. PMID: 32642376; PMCID: PMC7336717.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gabriela Jankowski , Kai Siemaszko, Mahmoud Badran, John Koladzyn, Marianna Jankowski, Luiza Wasilewski , Gregory Twombly, Weronika Margielewska, Anna Słodyczka

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 71
Number of citations: 0